Skip to main content
OpenTrials

Clinical trial condition

Philadelphia Positive (Ph+) Chronic Myelogenous Leukemia

Explore clinical trials studying Philadelphia Positive (Ph+) Chronic Myelogenous Leukemia. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies
Refine in advanced search Browse all conditions

Philadelphia Positive (Ph+) Chronic Myelogenous Leukemia trial results

Completed

Open Label, Phase II Study to Evaluate Efficacy and Safety of Oral Nilotinib in Philadelphia Positive (Ph+) Chronic Myelogenous Leukemia (CML) Pediatric Patients.

NCT01844765

Conditions
Bone Marrow Diseases, Bronchial Diseases, Bronchiolitis, +23 more
Locations
  • Loma Linda University Cancer Center Loma Linda, California, United States
  • Lucile Salter Packard Children's Hospital at Stanford Palo Alto, California, United States
  • Nemours Childrens Hospital Orlando, Florida, United States
  • St. Mary's Hospital West Palm Beach, Florida, United States
View all 36 locations
View Trial Details

Related conditions